Art

J-GLOBAL ID：202002247196158398   Reference number：20A0501649

Advanced Glycation End Products: Potential Mechanism and Therapeutic Target in Cardiovascular Complications under Diabetes

糖化最終産物:糖尿病下の心血管合併症における潜在的機序と治療標的【JST・京大機械翻訳】

Author (5)： Yang Ping (Department of Vasculocardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China) ,  Feng Jian (Department of Vasculocardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China) ,  Peng Qing (Department of Vasculocardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China) ,  Liu Xing (Department of Vasculocardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China) ,  Fan Zhongcai (Department of Vasculocardiology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China)
Material： Oxidative Medicine and Cellular Longevity (Web)  (Oxidative Med Cell Longev (Web))
Volume： 2019  Page： Null  Publication year： 2019 
JST Material Number： U7012A  ISSN： 1942-0900  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： The occurrence and development...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A0501649&from=J-GLOBAL&jstjournalNo=U7012A") }}

Thesaurus term： interaction ,  cardiovascular system ,  hyperglycemia ,  mortality ,  oxidative stress ,  *diabetes mellitus ,  receptor
Semi thesaurus term： 心血管イベント ,  糖尿病患者 ,  *治療標的 ,  *心血管合併症 ,  *進行性糖化最終産物 , 【Automatic Indexing@JST】

JST classification (2)： Metabolic diseases,nutritional diseases in general.  (GD05010J) ,  Diagnostics of metabolic diseases,nutritional diseases.  (GD05020U)

Reference (143)：

• G. B. D. Disease, I. Injury, C. Prevalence, "Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016," The Lancet, vol. 390, no. 10100, pp. 1211-1259, 2017.
• N. H. Cho, J. E. Shaw, S. Karuranga, Y. Huang, J. D. da Rocha Fernandes, A. W. Ohlrogge, B. Malanda, "IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045," Diabetes Research and Clinical Practice, vol. 138, pp. 271-281, 2018.
• S. Basu, J. S. Yudkin, S. Kehlenbrink, J. I. Davies, S. H. Wild, K. J. Lipska, J. B. Sussman, D. Beran, "Estimation of global insulin use for type 2 diabetes, 2018-30: a microsimulation analysis," The Lancet Diabetes & Endocrinology, vol. 7, no. 1, pp. 25-33, 2019.
• F. Paneni, T. F. Luscher, "Cardiovascular protection in the treatment of type 2 diabetes: a review of clinical trial results across drug classes," The American Journal of Cardiology, vol. 120, no. 1S, pp. S17-S27, 2017.
• C. Sardu, C. De Lucia, M. Wallner, G. Santulli, "Diabetes mellitus and its cardiovascular complications: new insights into an old disease," Journal Diabetes Research, vol. 2019, article 1905194, pp. 2, 2019.

Terms in the title (4)： 糖化最終産物 ,  糖尿病 ,  心血管合併症 ,  治療標的